CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...